Cargando…
Short- and long-term use of medication for psychological distress after the diagnosis of cancer
PURPOSE: This study investigated the short- and long-term use of medication for psychological distress after the diagnosis of cancer. METHODS: Longitudinal data from the Taiwan National Health Insurance database were used to follow 35,137 cancer patients for 2.5 years after being diagnosed in 2006 a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266776/ https://www.ncbi.nlm.nih.gov/pubmed/27785583 http://dx.doi.org/10.1007/s00520-016-3456-z |
_version_ | 1782500511392464896 |
---|---|
author | Wang, Cheng-Hsu Huang, Lynn Chu Yang, Chen-Chang Chen, Chi-Liang Chou, Yiing-Jenq Chen, Yen-Yuan Yang, Wei-Chih Chen, Likwang |
author_facet | Wang, Cheng-Hsu Huang, Lynn Chu Yang, Chen-Chang Chen, Chi-Liang Chou, Yiing-Jenq Chen, Yen-Yuan Yang, Wei-Chih Chen, Likwang |
author_sort | Wang, Cheng-Hsu |
collection | PubMed |
description | PURPOSE: This study investigated the short- and long-term use of medication for psychological distress after the diagnosis of cancer. METHODS: Longitudinal data from the Taiwan National Health Insurance database were used to follow 35,137 cancer patients for 2.5 years after being diagnosed in 2006 and 2007. RESULTS: Among those patients who survived for at least 180 days, 20.9 % had used psychotropic medications; sedatives were the most frequently prescribed (14.3 %), followed by antidepressants (5.5 %), anxiolytics (3.6 %), and antipsychotics (2.7 %). Lung cancer, prostate cancer, and oral cancer showed a significant association with the regular use of medication in the first 180 days. Among patients who survived for at least 2.5 years, 4.8 % still used psychotropic medication on a regular basis. Lung cancer and prostate cancer were associated with such prolonged use. CONCLUSIONS: This longitudinal study found that the type of cancer was significantly associated with the use of psychotropic drugs after the diagnosis was made. It provided information about the trajectory of that use and found that a small number of patients were still using those medications after 2.5 years. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00520-016-3456-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5266776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-52667762017-02-09 Short- and long-term use of medication for psychological distress after the diagnosis of cancer Wang, Cheng-Hsu Huang, Lynn Chu Yang, Chen-Chang Chen, Chi-Liang Chou, Yiing-Jenq Chen, Yen-Yuan Yang, Wei-Chih Chen, Likwang Support Care Cancer Original Article PURPOSE: This study investigated the short- and long-term use of medication for psychological distress after the diagnosis of cancer. METHODS: Longitudinal data from the Taiwan National Health Insurance database were used to follow 35,137 cancer patients for 2.5 years after being diagnosed in 2006 and 2007. RESULTS: Among those patients who survived for at least 180 days, 20.9 % had used psychotropic medications; sedatives were the most frequently prescribed (14.3 %), followed by antidepressants (5.5 %), anxiolytics (3.6 %), and antipsychotics (2.7 %). Lung cancer, prostate cancer, and oral cancer showed a significant association with the regular use of medication in the first 180 days. Among patients who survived for at least 2.5 years, 4.8 % still used psychotropic medication on a regular basis. Lung cancer and prostate cancer were associated with such prolonged use. CONCLUSIONS: This longitudinal study found that the type of cancer was significantly associated with the use of psychotropic drugs after the diagnosis was made. It provided information about the trajectory of that use and found that a small number of patients were still using those medications after 2.5 years. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00520-016-3456-z) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-10-26 2017 /pmc/articles/PMC5266776/ /pubmed/27785583 http://dx.doi.org/10.1007/s00520-016-3456-z Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Wang, Cheng-Hsu Huang, Lynn Chu Yang, Chen-Chang Chen, Chi-Liang Chou, Yiing-Jenq Chen, Yen-Yuan Yang, Wei-Chih Chen, Likwang Short- and long-term use of medication for psychological distress after the diagnosis of cancer |
title | Short- and long-term use of medication for psychological distress after the diagnosis of cancer |
title_full | Short- and long-term use of medication for psychological distress after the diagnosis of cancer |
title_fullStr | Short- and long-term use of medication for psychological distress after the diagnosis of cancer |
title_full_unstemmed | Short- and long-term use of medication for psychological distress after the diagnosis of cancer |
title_short | Short- and long-term use of medication for psychological distress after the diagnosis of cancer |
title_sort | short- and long-term use of medication for psychological distress after the diagnosis of cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266776/ https://www.ncbi.nlm.nih.gov/pubmed/27785583 http://dx.doi.org/10.1007/s00520-016-3456-z |
work_keys_str_mv | AT wangchenghsu shortandlongtermuseofmedicationforpsychologicaldistressafterthediagnosisofcancer AT huanglynnchu shortandlongtermuseofmedicationforpsychologicaldistressafterthediagnosisofcancer AT yangchenchang shortandlongtermuseofmedicationforpsychologicaldistressafterthediagnosisofcancer AT chenchiliang shortandlongtermuseofmedicationforpsychologicaldistressafterthediagnosisofcancer AT chouyiingjenq shortandlongtermuseofmedicationforpsychologicaldistressafterthediagnosisofcancer AT chenyenyuan shortandlongtermuseofmedicationforpsychologicaldistressafterthediagnosisofcancer AT yangweichih shortandlongtermuseofmedicationforpsychologicaldistressafterthediagnosisofcancer AT chenlikwang shortandlongtermuseofmedicationforpsychologicaldistressafterthediagnosisofcancer |